|
- Introducing the iLet Bionic Pancreas - Beta Bionics
The iLet is an automated insulin delivery system that reduces the need to make decisions about your diabetes management – because it makes the decisions for you
- 100 Days with the iLet Bionic Pancreas: One Woman’s Type 1 . . .
After 42 years with type 1 diabetes, Peterson discusses how automating 100% of her insulin dosing with the iLet helped simplify glucose management, restore food freedom and ease the burden of diabetes care
- Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s . . .
The iLet is the first insulin delivery system in the United States to connect to Abbott’s FreeStyle Libre 3 Plus sensor, whose readings every minute will help the iLet calculate insulin doses
- Assessing the iLet Bionic Pancreas Deployed in Primary Care and via . . .
The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH)
- What is the iLet Bionic Pancreas? – FAQ
The iLet Bionic Pancreas is an automated insulin delivery system that communicates with a user’s CGM sensor and makes 100% of insulin dosing decisions without any carb counting*, correction factors, carb ratios, or pre-set basal rates
- iLet Insulin Pump - Integrated Diabetes Services
The iLet is a groundbreaking insulin pump designed to automate much of diabetes management by taking over insulin dosing decisions With minimal input beyond meal announcements, it aims to reduce the daily burden of calculations and adjustments
- iLet Bionic Pancreas System - ADA Consumer Guide
The iLet Bionic Pancreas system by Beta Bionics is an automated insulin delivery system composed of the iLet ACE Pump, iLet Dosing Decision Software, and a continuous glucose monitor The pump’s dosing is initiated solely based on the user’s weight
- The Beta Bionics iLet Bionic Pancreas System: A Breakthrough in . . .
The iLet system aims to maintain glucose levels within a target range of 70–180 mg dL (3 9–10 mmol L) Settings are automatically adjusted based on individual needs, and users can adjust targets for specific situations, such as exercise or illness
|
|
|